RASSF1 and breast cancer: Because a functional relationship between DNA hypermethylation and the silencing of RASSF1A transcripts in breast cancer cells has been described [14], we next investigated whether demethylation of the RASSF1A promoter after TMCG/DIPY treatment was accompanied by an increase in expression of the RASSF1A transcript.